"Immunocompromised Host" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
| Descriptor ID |
D016867
|
| MeSH Number(s) |
G12.470
|
| Concept/Terms |
Immunocompromised Host- Immunocompromised Host
- Host, Immunocompromised
- Hosts, Immunocompromised
- Immunocompromised Hosts
- Immunocompromised Patient
- Immunocompromised Patients
- Patient, Immunocompromised
- Patients, Immunocompromised
- Immunosuppressed Host
- Host, Immunosuppressed
- Hosts, Immunosuppressed
- Immunosuppressed Hosts
|
Below are MeSH descriptors whose meaning is more general than "Immunocompromised Host".
Below are MeSH descriptors whose meaning is more specific than "Immunocompromised Host".
This graph shows the total number of publications written about "Immunocompromised Host" by people in this website by year, and whether "Immunocompromised Host" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 3 | 5 |
| 1997 | 1 | 1 | 2 |
| 1998 | 3 | 1 | 4 |
| 1999 | 1 | 1 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 2 | 3 | 5 |
| 2004 | 2 | 2 | 4 |
| 2005 | 1 | 1 | 2 |
| 2006 | 4 | 4 | 8 |
| 2007 | 2 | 1 | 3 |
| 2008 | 2 | 4 | 6 |
| 2009 | 2 | 5 | 7 |
| 2010 | 2 | 3 | 5 |
| 2011 | 4 | 6 | 10 |
| 2012 | 1 | 5 | 6 |
| 2013 | 5 | 2 | 7 |
| 2014 | 3 | 5 | 8 |
| 2015 | 3 | 4 | 7 |
| 2016 | 3 | 4 | 7 |
| 2017 | 1 | 11 | 12 |
| 2018 | 5 | 3 | 8 |
| 2019 | 7 | 5 | 12 |
| 2020 | 3 | 4 | 7 |
| 2021 | 5 | 11 | 16 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 2 | 2 |
| 2024 | 5 | 2 | 7 |
| 2025 | 1 | 2 | 3 |
| 2026 | 4 | 3 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunocompromised Host" by people in Profiles.
-
Fatal Rickettsia parkeri Rickettsiosis in Immunocompromised Pediatric Patient, Georgia, USA, 2025. Emerg Infect Dis. 2026 Nov; 32(11):1893-1896.
-
IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients. Clin Infect Dis. 2026 08 24; 82(Suppl 3):i105-i110.
-
Spatial biology reveals altered macrophage states in immunosuppressed non-melanoma skin cancer. Cell. 2026 Sep 17; 189(19):6170-6188.e9.
-
Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Diseases in Pediatric Transplant Patients. Transpl Infect Dis. 2026 Sep-Oct; 28(5):e70272.
-
Characteristics of progressive multifocal leukoencephalopathy in hematological malignancies, With reference to HIV-infected patients. Int J Hematol. 2026 Nov; 124(5):723-734.
-
Vaccination for Patients With Immunosuppression and Altered Immunity: A Workgroup Report from the AAAAI Adverse Reactions to Drugs, Biologics, and Vaccines Committee and the Autoimmunity and Altered Immune Response Committee. J Allergy Clin Immunol Pract. 2026 07; 14(7):1549-1561.
-
Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT. Transplant Cell Ther. 2026 Sep; 32(9):1051.e1-1051.e10.
-
Limosilactobacillus reuteri alleviates proinflammatory T-cell-mediated liver injury and transcriptomic changes in immunocompromised mice. Front Immunol. 2026; 17:1713120.
-
Adenovirus Disease Following Pediatric Liver Transplantation: 10-Year Experience From a Large Pediatric Transplant Program. Pediatr Transplant. 2026 Mar; 30(3):e70298.
-
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness. Clin Infect Dis. 2026 01 16; 81(Suppl 3):i1-i5.